From health systems to individuals, nephrolithiasis is economically burdensome. The aim of the current paper is to characterize the financial burden of disease associated with nephrolithiasis with an emphasis on investigating treatment modality economic efficiency.
For small volume practices and cases where there is high risk of scope damage, disposable flexible ureteroscope utilization seems to provide economic efficiency. The rise in global prevalence of stone disease is a large contributing factor to increasing costs associated with nephrolithiasis. A large proportion of costs from kidney stones stem from ED visits and inpatient care. There are opportunities to save money by transitioning care to outpatient settings in scenarios that allow such transition. Metaphylaxis and prevention strategies are effective at lowering costs in properly selected patient populations. Flexible ureteroscopy and percutaneous nephrolithotomy (PCNL) are the most economically efficient methods of surgically treating stone disease, with PCNL being reserved for large and lower pole stones. Time off work and other indirect costs, while challenging to quantify, are important considerations in the economics of nephrolithiasis.
Current urology reports. 2020 Mar 31*** epublish ***
Daniel Roberson, Colin Sperling, Ankur Shah, Justin Ziemba
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/32236700